Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

59-14-3 - 5-Bromo-2'-deoxyuridine, 99% - 5-Bromo-1-(2-deoxy-beta-D-ribofuranosyl)uracil - 5-BrdU - H27260 - Alfa Aesar

H27260 5-Bromo-2'-deoxyuridine, 99%

CAS-Nummer
59-14-3
Synonyme
5-Bromo-1-(2-deoxy-beta-D-ribofuranosyl)uracil
5-BrdU

Größe Preis ($) Menge Verfügbarkeit
250mg 31,93
1g 83,84
5g 266,77
Zum Warenkorb hinzufügen Zur Angebotsanfrage hinzufügen Artikel anzeigen

5-Bromo-2'-deoxyuridine, 99%

MDL
MFCD00006529
EINECS
200-415-9

Chemische Eigenschaften

Formel
C9H11BrN2O5
Molmasse
307.10
Schmelzpunkt
ca 190° dec.
Löslichkeit
Soluble in water.

Anwendungen

5-Bromo-2'-deoxyuridine (BrdU) is a thymidine analog used to label DNA. It is incorporated into newly synthesized DNA in place of thymidine during the S phase of the cell cycle. Cells that were actively proliferating can then be detected by denaturing the DNA and allowing specific antibodies to target the BrdU incorporation. Consequently 5-BrdU is used to study cell signaling and other processes that induce cell proliferation.

Bemerkungen

Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Store away from strong oxidizing agents.

Literaturverweise

Chen Li,; Avrum I. Gotlieb. Transforming Growth Factor-β Regulates the Growth of Valve Interstitial Cellsin Vitro. The American Journal of Pathology. 2011, 179 (4), 1746-1755 .

Yu Gui et. al. Signaling mechanisms mediating uridine adenosine tetraphosphate-induced proliferation of human vascular smooth muscle cells. Journal of Cardiovascular Pharmacology. 2011 , 58(6), 654-662 .

Thymidine analog, preferentially incorporated into cellular DNA in place of thymidine, producing increased radiosensitivity of the cell: Int. J. Radiat. Oncol. Biol. Phys., 10, 1399 (1984); 21, 709 (1991). Mutagen used in genetic research: Mutat. Res., 258, 161 (1991). Reviews on use in diagnostics and research: Histochem. J., 27, 339, 923 (1995; 28, 531 (1996).

GHS Gefahren- und Sicherheitshinweise

Gefahrenhinweise (EU): H341

Suspected of causing genetic defects.

Sicherheitshinweise: P201-P281-P202-P308+P313-P405-P501a

Obtain special instructions before use. Use personal protective equipment as required. Do not handle until all safety precautions have been read and understood. IF exposed or concerned: Get medical advice/attention. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.

Weitere Referenzen

Merck
14,1452
Beilstein
30395
Harmonized Tariff Code
2934.99
TSCA
Yes
RTECS
YU7350000

Empfohlen

Kürzlich angesehen

Chemikalien

Life science

Metalle und Stoffe

Katalysatoren

Forschungs- und Laborbedarf